Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03WNN
|
||||
Former ID |
DIB003059
|
||||
Drug Name |
RG-7010
|
||||
Synonyms |
R-7010; PEGylated IGF1 (amyotrophic lateral sclerosis), Roche
|
||||
Indication | Motor neurone disease [ICD9: 335.2; ICD10:G12.2] | Phase 1 | [548987] | ||
Company |
F Hoffmann-La Roche Ltd
|
||||
Target and Pathway | |||||
Target(s) | Insulin-like growth factor I receptor | Target Info | Modulator | [548988] | |
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
HIF-1 signaling pathway | |||||
FoxO signaling pathway | |||||
Oocyte meiosis | |||||
Endocytosis | |||||
PI3K-Akt signaling pathway | |||||
AMPK signaling pathway | |||||
Focal adhesion | |||||
Adherens junction | |||||
Signaling pathways regulating pluripotency of stem cells | |||||
Long-term depression | |||||
Ovarian steroidogenesis | |||||
Progesterone-mediated oocyte maturation | |||||
Pathways in cancer | |||||
Transcriptional misregulation in cancer | |||||
Proteoglycans in cancer | |||||
Glioma | |||||
Prostate cancer | |||||
Melanoma | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.